Researchers find biomarker for early onset GVHD after transplant

01/8/2010 | Science News

Researchers have discovered that a protein called elafin showed up in greater concentrations among bone marrow transplant patients who exhibited a skin rash after the procedure and developed graft-versus-host disease later on compared with those who did not develop the disease. The new protein biomarker could help determine whether skin rash is a sign of early developing GVHD after bone marrow transplant, as well as identify the patients who need more aggressive treatment, the researchers said.

View Full Article in:

Science News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN